Open report — full analysis, no account required.
Sign up to generate reports and read filings that aren't on the open list.
Get notified when LAB files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsStandard BioTools regains Nasdaq compliance after stock price recovers above $1
Filed June 5, 2026 · Period ending June 5, 2026 · ~1 min read
Key Changes
-
medium
Company received formal notice from Nasdaq on June 5, 2026 that it has regained compliance with the minimum $1.00 bid price requirement, resolving a deficiency that began in April when the stock traded below $1 for 30 consecutive days.
Item 3.01 view on EDGAR → -
medium
The stock had fallen below the $1.00 minimum bid price threshold for 30 consecutive business days through mid-April 2026, triggering a deficiency notice on April 20, 2026 that threatened the company's Nasdaq Global Select Market listing.
8-K: Compliance Notice view on EDGAR →
Summary
Standard BioTools has successfully resolved a Nasdaq listing compliance issue after its stock price recovered above the exchange's minimum $1.00 bid price requirement. The company received formal notification on June 5, 2026 that the deficiency matter is now closed, following a period in April when shares traded below $1 for 30 consecutive business days.
For retail investors, this is positive news that removes the immediate threat of delisting from the Nasdaq Global Select Market, which would have reduced liquidity and institutional ownership. However, the fact that the stock fell below $1 in the first place signals underlying business or market concerns that caused the price weakness.
Investors should monitor whether the stock price remains stable above $1 going forward. A return to sub-$1 levels would restart the compliance clock and could indicate continued fundamental challenges. Watch for the company's next quarterly earnings report for insight into business performance that drove the initial price decline.
Section-by-Section Diff
Event · Item 8.01 — Other Events
Item 8.01 — Other Events filed; see Key Changes for terms.
Added in current filing · verify on EDGAR →
on April 20, 2026, the Company received written notice from the Staff of Nasdaq notifying the Company that, because the closing bid price for the Company’s common stock, par value $0.001 per share, had fallen below $1.00 per share for 30 consecutive business days, the Company no longer met the minimum bid price requirement for continued inclusion on The Nasdaq Global Select Market pursuant to the Bid Price Requirement.
The company had previously fallen out of compliance with Nasdaq listing requirements when its stock price remained below $1.00 for 30 consecutive business days through mid-April 2026. This deficiency has now been cured, and the matter is closed.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · Jun 5, 2026 · How we verify